Search
for

    Sort by

    Research 421–450 of 808

    1. Male hormonal contraception: looking back and moving forward Andrology · 2015 · 23 citations
    2. Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies Breast Cancer Research and Treatment · 2018 · 22 citations
    3. Testosterone target therapy: focus on immune response, controversies and clinical implications in patients with COVID-19 infection Therapeutic Advances in Endocrinology and Metabolism · 2021 · 21 citations
    4. Pharmacologic Treatment of Polycystic Ovary Syndrome Seminars in reproductive medicine · 2003 · 21 citations
    5. Levonorgestrel effects on serum androgens, sex hormone–binding globulin levels, hair shaft diameter, and sexual function Fertility and Sterility · 2009 · 20 citations
    6. Selective androgen receptor modulators (SARMs) have specific impacts on the mouse uterus Journal of Endocrinology · 2019 · 19 citations
    7. Anti-Müllerian Hormone and Polycystic Ovary Syndrome in Women and Its Male Equivalent Biomedicines · 2022 · 18 citations
    8. Novel insights into the pathways regulating the canine hair cycle and their deregulation in alopecia X PLOS ONE · 2017 · 18 citations
    9. MANAGEMENT OF ENDOCRINE DISEASE Hyperandrogenic states in women: pitfalls in laboratory diagnosis European Journal of Endocrinology · 2018 · 16 citations
    10. Therapeutic options in the polycystic ovary syndrome Journal of Obstetrics and Gynaecology · 2007 · 16 citations
    11. International PCOS guideline clinical research priorities roadmap: a co-designed approach aligned with end-user priorities in a neglected women’s health condition EClinicalMedicine · 2024 · 15 citations
    12. Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender Population Frontiers in Endocrinology · 2021 · 15 citations
    13. Helpful diagnostic markers of steroidogenesis for defining hyperandrogenemia in hirsute women Steroids · 2007 · 14 citations
    14. Role of anabolic agents in colorectal carcinogenesis: Myths and realities (Review) Oncology Reports · 2019 · 13 citations
    15. Long-Term Response of Hirsutism and Other Hyperandrogenic Symptoms to Combination Therapy in Polycystic Ovary Syndrome Journal of Womens Health · 2018 · 13 citations
    16. Understanding key symptoms, side effects, and impacts of HR+/HER2- advanced breast cancer: qualitative study findings Journal of patient-reported outcomes · 2019 · 12 citations
    17. Endocrine treatment of benign prostatichypertrophy: Current concepts Urology · 1991 · 11 citations
    18. Deciphering the Role of Androgen in the Dermatologic Manifestations of Polycystic Ovary Syndrome Patients: A State-of-the-Art Review Diagnostics · 2024 · 10 citations
    19. Polycystic Ovary Syndrome Journal of Pharmacy Practice · 2010 · 10 citations
    20. Choice of treatment for women with polycystic ovary syndrome Fertility and Sterility · 2006 · 10 citations
    21. Testosterone Therapy in Premenopausal Women Seminars in Reproductive Medicine · 2006 · 10 citations
    22. Polycystic ovary syndrome Journal Of Endocrinology, Metabolism And Diabetes Of South Africa · 2009 · 9 citations
    23. Epigenetic regulation of 5α reductase-1 underlies adaptive plasticity of reproductive function and pubertal timing BMC Biology · 2022 · 8 citations
    24. Common urologic diseases in older men and their treatment: how they impact fertility Fertility and Sterility · 2017 · 8 citations
    25. A systematic review of health-related quality of life outcomes in patients with advanced breast cancer treated with palbociclib Journal of Comparative Effectiveness Research · 2024 · 7 citations
    26. A Review of the Most Common Dermatologic Conditions and their Debilitating Psychosocial Impacts International archives of internal medicine · 2019 · 7 citations
    27. Transgender and Migraine Headache · 2019 · 7 citations
    28. Endocrinopathies and Other Disorders Inducing a Polycystic Ovary Syndrome Phenotype S. Karger AG eBooks · 2012 · 7 citations
    29. Pharmacokinetics of Modified Slow-Release Oral Testosterone Over 9 Days in Normal Men With Experimental Hypogonadism International Journal of Andrology · 2012 · 7 citations
    30. Drug safety evaluation of exemestane Expert Opinion on Drug Safety · 2011 · 7 citations